MENU
+Compare
ATRC
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$37.16
Change
-$0.08 (-0.21%)
Capitalization
1.85B

ATRC AtriCure Forecast, Technical & Fundamental Analysis

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors... Show more

ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATRC with price predictions
Oct 17, 2025

ATRC in downward trend: 10-day moving average moved below 50-day moving average on October 03, 2025

The 10-day moving average for ATRC crossed bearishly below the 50-day moving average on October 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ATRC broke above its upper Bollinger Band on October 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 09, 2025. You may want to consider a long position or call options on ATRC as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ATRC just turned positive on October 10, 2025. Looking at past instances where ATRC's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

ATRC moved above its 50-day moving average on October 15, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for ATRC moved above the 200-day moving average on September 16, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.976) is normal, around the industry mean (10.742). P/E Ratio (0.000) is within average values for comparable stocks, (53.915). ATRC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.793). ATRC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.519) is also within normal values, averaging (13.572).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATRC is expected to report earnings to fall 13.00% to -11 cents per share on October 29

AtriCure ATRC Stock Earnings Reports
Q3'25
Est.
$-0.11
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.02
The last earnings report on July 29 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 214.73K shares outstanding, the current market capitalization sits at 1.85B.
A.I. Advisor
published General Information

General Information

a manufacturer of surgical and medical instruments

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
7555 Innovation Way
Phone
+1 513 755-4100
Employees
1200
Web
https://www.atricure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACSYX31.560.17
+0.54%
Invesco Comstock C
GCPNX21.450.11
+0.52%
Gateway Equity Call Premium N
FIKEX59.99N/A
N/A
Fidelity Advisor Industrials Z
TEFQX5.31-0.03
-0.56%
Firsthand Technology Opportunities
VGPMX18.89-0.18
-0.94%
Vanguard Global Capital Cycles Investor

ATRC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-0.21%
CERS - ATRC
42%
Loosely correlated
-3.16%
SIBN - ATRC
41%
Loosely correlated
-2.38%
ISRG - ATRC
40%
Loosely correlated
+2.65%
IRMD - ATRC
38%
Loosely correlated
-3.45%
TMCI - ATRC
37%
Loosely correlated
+0.94%
More

Groups containing ATRC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-0.21%
Pharmaceuticals: Other
industry (103 stocks)
26%
Poorly correlated
+0.16%
Pharmaceuticals
industry (383 stocks)
26%
Poorly correlated
-0.25%